Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences

The new name better reflects its business model combining MDx testing with the drug discovery and development services business it acquired from Cancer Genetics.

Pfizer Inks Deal for Access to Centogene Rare Disease Data

Centogene's data repository includes rare disease patient data including clinical information, health records, and a range of -omics data.

Centogene Prices US IPO at $14 per Share

The German company offers rare disease genetic tests and services for clinical applications, as well as to support drug discovery and development programs.

Cellular Analytics Eyes Drug Development Space with Circulating Tumor Cell Capture Platform

Premium

Emerging from stealth mode, the Toronto-based firm will use the platform to identify circulating tumor cells and spur drug development in the lung cancer space.

Envisagenics Awarded $300K NCI Grant to Refine Drug Discovery Tech

The company's SpliceCore platform maps patient RNA sequencing data to a collection of over 5 million alternative splicing errors to pinpoint ones that cause disease.

Oct 17, 2019

Centogene Files to Go Public in US

Oct 10, 2019

UTC Labs, Principals Agree to Pay $42.6M in PGx Testing Fraud Case

Oct 09, 2019

Fauna Bio Awarded $229K NIH Grant for Animal Genomics-Based Drug Discovery Platform

Oct 09, 2019

Evotec, Celmatix Partner on Women's Reproductive Health Drug Discovery

Sep 30, 2019

Sciex, Protein Metrics Partner on Mass Spec Data Analysis

Sep 30, 2019

Bioanalytical Instrumentation Firm Creoptix Raises CHF 8M

Sep 26, 2019

23andMe, TrialSpark Request Proposals for New Joint Clinical Trial Offering

Sep 26, 2019

A-Alpha Bio Raises $2.8 million in Seed Financing to Develop NGS-Based Protein Interaction Tech

Premium

Sep 17, 2019

Amgen, Adaptive Biotechnologies Expand Partnership on NGS Blood Cancer Monitoring

Sep 16, 2019

Interpace Diagnostics, Genecast Biotechnology Ink Worldwide Research Services Agreement

Sep 09, 2019

Personalis to Profile CLL Patients in Invectys Phase II Drug Trial

Aug 15, 2019

GeneCentric Therapeutics to Launch Phase II Validation Study for Head and Neck Cancer Subtyper

Premium

Aug 15, 2019

GeneCentric Therapeutics Acquires Select ImmunoGenomics

Aug 15, 2019

HiFiBio Bets on Single-Cell Methods to Boost Drug Discovery

Premium

Aug 13, 2019

Adaptive Biotechnologies Q2 Revenues Rise 91 Percent

Aug 06, 2019

Sophia Genetics Teams With ADC Therapeutics on Biomarker Discovery for Lymphoma Treatment

Jul 30, 2019

Swiss Startup QGel Commercializing 3D Organoids for Cancer Drug Response Research

Premium

Jul 29, 2019

NEC Acquires Bioinformatics Firm OncoImmunity

Jul 24, 2019

Gray Foundation Awards $25M in Cancer Research Grants

Jul 17, 2019

Cancer Drug Discovery Firm Notable Nabs $40M in Series B Funding Round

Breaking News

The Scan

More Troubling Resistance

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

Many Dollar Bills There

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

'Transparency' Rule Proposed

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

Nature Papers Present Method for Simulating Hi-C Data, More

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.

Featured White Papers

5 Risks Researchers Take by Not Prioritizing Metabolomics in Drug Development

The Keys to Harnessing the True Power of Metabolomics

Metabolomics: The Unexpected Key to Building Value in Drug Discovery and Development

Dec

04

Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

Dec

10

Featured Webinar

Maximizing Diagnostic Yield with an Optimized Variant Interpretation Platform

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.

Menu

Drug Discovery & Development

What's Popular?

Sponsorships